1. GLOBOCAN. Estimated cancer incidence, mortality and prevalence worldwide in 2012. 2012. www.globocan.iarc.fr/Pages/fact_sheets_population.aspx . Assessed 23 Feb 2016.
2. Jahnke V, Strange R, Matthias C, Fryer AA. Initial results of glutathione-S-transferase GSTM1 and GSTT1 genotypes and genetic predisposition for laryngeal carcinoma. Laryngorhinootologie. 1995;74(11):691–4.
3. Maier H, Tisch M. Epidemiology of laryngeal cancer: results of the Heidelberg case-control study. Acta Otolaryngol Suppl. 1997;527:160–4.
4. Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA, editors. SEER cancer statistics review. Bethesda: National Cancer Institute; 1975–2012. http://seer.cancer.gov/csr/1975_2012/ , based on November 2014 SEER data submission, posted to the SEER web site, April 2015. Accessed 23 Feb 2016.
5. Russell JO, Scharf J. Premalignant and early malignant lesions of the larynx. In: Sataloff RT, Series editor, Benninger MS, volume editor. Sataloff’s comprehensive textbook of otolaryngology: head and neck surgery: laryngology, vol. 4). New Delhi: Jaypee Brothers Medical Publishers (P) Ltd; 2016.